Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Blockchain

XRP Faces Sharp Decline Following Scheduled Token Release

Robert Sasse by Robert Sasse
December 1, 2025
in Blockchain, Ethereum & Altcoins, Trading & Momentum
0
XRP Stock
0
SHARES
35
VIEWS
Share on FacebookShare on Twitter

The first trading days of December delivered a harsh reality check for XRP holders, as the digital asset’s value plunged nearly 8% to hover around $2.00. This significant drop coincided with Ripple’s monthly procedure of releasing one billion tokens from escrow, sparking renewed debate about near-term price pressures.

Institutional Demand Contrasts Retail Nervousness

A striking divergence is unfolding in the market. Even as the price retreated from $2.46 to approximately $2.02, institutional investment products tied to XRP witnessed substantial inflows, exceeding $644 million. This pattern suggests large-scale investors may view the dip, particularly below the $2.10 level, as a strategic buying opportunity.

However, on-chain data reveals heightened anxiety among a broader set of market participants. Trading volume surged to $4.22 billion, indicating that fears of increased token supply are prompting significant selling activity. The concern centers on whether buyers can absorb this potential sell-side pressure.

Understanding the Monthly Escrow Event

Ripple’s release of precisely one billion XRP on December 1—valued at roughly two billion dollars—is a scheduled, recurring event. Historically, the company has relocked 70% to 80% of these tokens within days. Despite this established pattern, the psychological impact on traders is often immediate, fostering expectations of short-term selling that can overshadow the technical reality.

Should investors sell immediately? Or is it worth buying XRP?

Technical Landscape and Long-Term Projections

From a chart perspective, XRP recently encountered firm resistance at the $2.46 level. A conclusive break above this barrier is needed to open a path toward $2.60, a scenario that now seems distant. The immediate focus has shifted to the crucial $2.00 support zone. A sustained drop below this psychological threshold could trigger further declines, while stabilization here might pave the way for recovery.

Beyond the current volatility, longer-term forecasts remain bullish. Analysts at Standard Chartered have projected a potential rise to $5.50 for XRP by the end of 2025. This outlook is contingent on stable regulatory developments and continued inflows into exchange-traded products. Before such targets can be considered, the asset must first reclaim the $2.20 region to reinforce the bullish structure established in the fourth quarter.

Ripple’s Strategic Developments

Separately, Ripple is advancing its ecosystem with the development of RLUSD, a regulated stablecoin. This asset is designed to work alongside XRP as collateral on the Ripple Prime platform, with the goal of providing institutional clients access to decentralized finance (DeFi) via the XRP Ledger. While this represents a substantial long-term growth initiative, it is not currently acting as a primary driver for the token’s price.

Ad

XRP Stock: Buy or Sell?! New XRP Analysis from March 25 delivers the answer:

The latest XRP figures speak for themselves: Urgent action needed for XRP investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

XRP: Buy or sell? Read more here...

Tags: XRP
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Ocugen Stock
Analysis

Ocugen Shares Tumble Despite Positive Clinical Trial Results

March 25, 2026
Coinbase Stock
Analysis

Regulatory Proposal Sparks Sell-Off in Coinbase Shares

March 25, 2026
Kuya Silver Corporation Stock
Analysis

Kuya Silver Shares Show Signs of Technical Recovery

March 24, 2026
Next Post
Cass Information Stock

Conflicting Indicators Create Uncertainty for Cass Information Shares

Exscientia Stock

Recursion Pharmaceuticals Navigates Tumultuous Transition Following Landmark Acquisition

LSB Industries Stock

LSB Industries Stock Breaks Key Barrier in Bullish Surge

Recommended

Rocket Companies Stock

Rocket Companies Stock Surges on Fed Policy Speculation

7 months ago
Biopharmaceutical Markets and money (1)

Groundbreaking Preclinical Data on TN301 A Potential Breakthrough in Treating HFpEF

2 years ago
Airbnb Stock

Airbnb Faces Dual Challenges as Insiders Sell and Fee Structure Shifts

7 months ago
MSCI World ETF Stock

MSCI World ETF Reaches New Heights Amid Tech Sector Surge

6 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Regulatory Proposal Sparks Sell-Off in Coinbase Shares

UnitedHealth Faces Multifaceted Regulatory Scrutiny Ahead of Earnings

Intel’s Capital Reshuffle and Leadership Transition Revealed in Annual Filing

35,000 Guards for 359 Million Doors: The Cyber Deficit Wall Street Can No Longer Ignore

Palo Alto Networks Finalizes Debt Terms Following CyberArk Acquisition

Kuya Silver Shares Show Signs of Technical Recovery

Trending

Oracle Stock
AI & Quantum Computing

Oracle’s Backlog Soars on Cloud and AI Contract Momentum

by Jackson Burston
March 25, 2026
0

While much of the market's attention remains fixed on the developers of large AI models, Oracle has...

Alphabet Stock

Regulatory Scrutiny Looms Over Alphabet’s Aggressive AI Expansion

March 25, 2026
Ocugen Stock

Ocugen Shares Tumble Despite Positive Clinical Trial Results

March 25, 2026
Coinbase Stock

Regulatory Proposal Sparks Sell-Off in Coinbase Shares

March 25, 2026
Unitedhealth Stock

UnitedHealth Faces Multifaceted Regulatory Scrutiny Ahead of Earnings

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Oracle’s Backlog Soars on Cloud and AI Contract Momentum
  • Regulatory Scrutiny Looms Over Alphabet’s Aggressive AI Expansion
  • Ocugen Shares Tumble Despite Positive Clinical Trial Results

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com